Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
The Journal of Clinical Investigation|September 18, 2009
Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiencyAndrew L Snow, Rebecca A Marsh, Scott M Krummey, et al.Blood|September 23, 2017
Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 studyElisabet Bergsten, AnnaCarin Horne, Maurizio Aricó, et al.Journal of Pediatric Gastroenterology and Nutrition|June 27, 2007
Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitisJennifer Z Bullock, Joyce M Villanueva, Carine Blanchard, et al.The Journal of Allergy and Clinical Immunology|December 31, 2003
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromesJennifer K Garrett, Sean C Jameson, Blythe Thomson, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2013
An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosisRebecca A Marsh, Mi-Ok Kim, Chunyan Liu, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group reportPaul J Martin, Daniel Weisdorf, Donna Przepiorka, et al.The Journal of Allergy and Clinical Immunology|November 11, 2008
Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needsLinda M Griffith, Morton J Cowan, Donald B Kohn, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group ReportKirk R Schultz, David B Miklos, Daniel Fowler, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab RegimenRebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.Blood|November 8, 2012
Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomesRebecca A Marsh, Kanchan Rao, Prakash Satwani, et al.Pageof 9